Abbott Asks For Reconsideration To End Stent FCA Suit
Abbott Laboratories asked a Texas federal judge Tuesday to rethink her decision forcing the company to face a whistleblower's False Claims Act lawsuit alleging it marketed stents for off-label uses, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article